Prostaglandin E2 increases proenkephalin mRNA level in rat astrocyte-enriched culture

Brain Res Mol Brain Res. 1998 Oct 1;60(2):203-14. doi: 10.1016/s0169-328x(98)00182-x.

Abstract

The effect of prostaglandin E2 (PGE2) on proenkephalin (proENK) mRNA expression in primary cultured rat astrocytes was studied. The proENK mRNA level was significantly increased about 3.3-fold 4 h after PGE2 (10 microM) treatment and this increase was potentiated by the pre-treatment with cycloheximide (CHX; 15 microM) about 1.7-fold as much as PGE2 alone treated cells. The pretreatment with staurosporine (1 microM) completely inhibited the increase of PGE2-induced proENK mRNA level, although only a partial inhibition of PGE2-induced proENK mRNA level (approximately 1.5-fold) by H89 (10 microM) was observed. The increase of PGE2-induced proENK mRNA level was not affected by the pretreatment with PD98059 (1, 5, and 10 microM), omega-conotoxin GIVA (1 microM), nimodipine (1 microM), calmidazolium (1 microM), or KN-62 (1 microM). In addition to the proENK mRNA level, PGE2 also increased c-Fos (approximately 4.3-fold), Fra-1 ( approximately 3.8 fold), and Fra-2 (approximately 8.2-fold) protein levels at 4 h after drug treatment. However, c-Jun, JunB, and JunD protein levels were not affected by PGE2. Indeed, PGE2 failed to up-regulate c-jun mRNA expression as well as its protein product. Surprisingly, although three Jun proteins were not induced by PGE2, AP-1 and ENKCRE-2 DNA binding activities were increased by PGE2, (approximately 5 and approximately 2.8-fold, respectively) and which were effectively reduced by CHX (approximately 2.5 and 2-fold, respectively). In western blot analyses, PGE2 enhanced the phosphorylation of CREB (approximately 2.6-fold at 1 h), and CHX showed a potentiative effect on PGE2-induced CREB phosphorylation ( approximately 1.7 fold at 1 h) which is similar to the action on proENK mRNA regulation. Our results suggest that PGE2 increases proENK mRNA expression via activating serine/threonine protein kinase such as PKA, but not calcium/calmodulin dependent protein kinase and MAPK. In addition, phosphorylation of CREB rather than the increase of AP-1 may have a possible role at least early stage in PGE2-induced proENK mRNA level and CHX-evoked potentiation.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Animals
  • Animals, Newborn
  • Astrocytes / cytology
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cerebral Cortex / metabolism*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Cycloheximide / pharmacology
  • Dinoprostone / pharmacology*
  • Enkephalins / biosynthesis
  • Enkephalins / genetics*
  • Enzyme Inhibitors / pharmacology*
  • Flavonoids / pharmacology
  • Imidazoles / pharmacology
  • Isoquinolines / pharmacology
  • Kinetics
  • Nimodipine / pharmacology
  • Peptides / pharmacology
  • Phosphorylation
  • Protein Precursors / biosynthesis
  • Protein Precursors / genetics*
  • Proto-Oncogene Proteins c-jun / genetics
  • RNA, Messenger / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Staurosporine / pharmacology
  • Sulfonamides*
  • Transcription Factor AP-1 / biosynthesis
  • Transcription Factor AP-1 / genetics
  • Transcription, Genetic / drug effects*
  • omega-Conotoxin GVIA

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Enkephalins
  • Enzyme Inhibitors
  • Flavonoids
  • Imidazoles
  • Isoquinolines
  • Peptides
  • Protein Precursors
  • Proto-Oncogene Proteins c-jun
  • RNA, Messenger
  • Sulfonamides
  • Transcription Factor AP-1
  • proenkephalin
  • calmidazolium
  • Nimodipine
  • KN 62
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • omega-Conotoxin GVIA
  • Cycloheximide
  • Staurosporine
  • Dinoprostone
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one